Lilly's CIALIS patent claims extending to physiologically acceptable salt found invalid for overbreadth and insufficiency | Smart & Biggar

On October 17, 2022, Justice St-Louis of the Federal Court granted a motion for summary trial brought by Teva, Pharmascience, Laboratoire Riva, Apotex and Mylan (the Defendants) and...

Related Keywords

Canada ,France ,Canadian ,Laboratoire Riva ,Eli Lilly Canada Incv Teva ,Justice St Louis ,Federal Court ,Canadian Patent ,Eli Lilly Canada Inc ,Teva Canada Limited ,Patented Medicines ,Asserted Claims ,